| Literature DB >> 11171916 |
G Schifitto1, K Kieburtz, M P McDermott, J McArthur, K Marder, N Sacktor, D Palumbo, O Selnes, Y Stern, L Epstein, S Albert.
Abstract
Cognitive and functional outcomes are of primary interest in the design of efficacy trials in HIV-associated cognitive impairment. In a longitudinal cohort study, weak associations were found between measures of cognitive performance and commonly used measures of daily functioning (mostly self-report measures) in HIV-infected individuals. Modifications of current functional scales or new functional instruments are needed to assess the clinical relevance of cognitive changes in clinical trials of HIV-associated cognitive impairment.Entities:
Mesh:
Year: 2001 PMID: 11171916 DOI: 10.1212/wnl.56.3.415
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910